31 January 2024 in The Journal of Physical Chemistry C
Efforts to study intricate, higher-order cellular functions have called for fluorescence imaging under physiologically relevant conditions such as tissue systems in simulated native buffers. This endeavor has presented novel challenges for fluorescent probes initially designed for use in simple buffers and monolayer cell culture. Among current fluorescent probes, semiconductor nanocrystals, or quantum dots (QDs), offer superior photophysical properties that are the products of their nanoscale architectures and chemical formulations. While their high brightness and photostability are ideal for these biological environments, even state of the art QDs can struggle under certain physiological conditions. A recent method correlating electron microscopy ultrastructure with single-QD fluorescence has begun to highlight subtle structural defects in QDs once believed to have no significant impact on photoluminescence (PL). Specific defects, such as exposed core facets, have been shown to quench QD PL in physiologically accurate conditions. For QD-based imaging in complex cellular systems to be fully realized, mechanistic insight and structural optimization of size and PL should be established. Insight from single QD resolution atomic structure and photophysical correlative studies provides a direct course to synthetically tune QDs to match these challenging environments.
25 June 2020 in Biochemistry
13 June 2023 in The Journal of Chemical Physics
The incorporation of quantum dots in display technology has fueled a renewed interest in InP-based quantum dots, but difficulty controlling the Zn chemistry during shelling has stymied thick, even ZnSe shell growth. The characteristic uneven, lobed morphology of Zn-based shells is difficult to assess qualitatively and measure through traditional methods. Here, we present a methodological study utilizing quantitative morphological analysis of InP/ZnSe quantum dots to analyze the impact of key shelling parameters on InP core passivation and shell epitaxy. We compare conventional hand-drawn measurements with an open-source semi-automated protocol to showcase the improved precision and speed of this method. Additionally, we find that quantitative morphological assessment can discern morphological trends in morphologies that qualitative methods cannot. In conjunction with ensemble fluorescence measurements, we find that changes to shelling parameters that promote even shell growth often do so at the cost of core homogeneity. These results indicate that the chemistry of passivating the core and promoting shell growth must be balanced carefully to maximize brightness while maintaining emission color-purity.
5 February 2026 in ACS Chemical Neuroscience
The human dopamine transporter (DAT) is a presynaptic transmembrane protein that facilitates the reuptake of synaptically released dopamine. Several lines of evidence indicate that DAT dysfunction is linked to neuropsychiatric disorders. Moreover, the lateral membrane diffusion and clustering propensity of DAT are emergent properties that may factor into functional dopamine signaling. The disorder-associated DAT missense mutant A559V undergoes anomalous dopamine efflux (ADE) and increased lateral mobility and diffuse localization. The D2 dopamine autoreceptor short isoform (D2S), a popular antipsychotic target, signaling augments ADE in DAT A559V and may form stable DAT-D2S complexes. Using quantum dot (Qdot)-based single-molecule localization microscopy, we investigated the effect of D2S antagonism on DAT and DAT A559V membrane mobility in transfected HEK-293 cells. Single-color Qdot-DAT tracking shows phenotypic rescue of DAT A559V mobility upon D2S antagonism, while aberrant DAT A559V mobility is insensitive to ADE-linked CaMKII activity. Using two-color Qdot tracking of both the transporter and receptor, we report the first DAT-D2S colocalization lifetime in live cells. We show an increased propensity for both transporter types to colocalize with D2S, without impacting D2S diffusion speed under D2S antagonism. Downregulating D2S activity may stabilize DAT coconfinement in D2S microdomains on the cell surface.